Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic Value Against Prostate Cancer by Molecular Docking Study

Mohammad Mijanur Rahman 1 , *
Author Information
1 Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 2015, 10 (1); e59673
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: February 13, 2014
  • Accepted: May 12, 2014
  • DOI: 10.17795/jjnpp-18216

To Cite: Rahman M M. Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic Value Against Prostate Cancer by Molecular Docking Study, Jundishapur J Nat Pharm Prod. 2015 ; 10(1):e59673. doi: 10.17795/jjnpp-18216.

Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Sriram D, Yogeeswari P. Medicinal Chemistry. 2010;
  • 2. Matsumoto T, Sakari M, Okada M, Yokoyama A, Takahashi S, Kouzmenko A, et al. The androgen receptor in health and disease. Annu Rev Physiol. 2013; 75: 201-24[DOI][PubMed]
  • 3. Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002; 20(13): 3001-15[PubMed]
  • 4. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol. 2002; 16(10): 2181-7[DOI][PubMed]
  • 5. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004; 25(2): 276-308[DOI][PubMed]
  • 6. Lonergan PE, Tindall DJ. Androgen receptor signaling in prostate cancer development and progression. J Carcinog. 2011; 10: 20[DOI][PubMed]
  • 7. Lee E, Madar A, David G, Garabedian MJ, Dasgupta R, Logan SK. Inhibition of androgen receptor and beta-catenin activity in prostate cancer. Proc Natl Acad Sci U S A. 2013; 110(39): 15710-5[DOI][PubMed]
  • 8. Nareeboon P, Komkhunthot W, Lekcharoen D, Wetprasit N, Piriyapolsart C, Sutthivaiyakit S. Acetylenic fatty acids, triglyceride and triterpenes from the leaves of Hymenodictyon excelsum. Chem Pharm Bull (Tokyo). 2009; 57(8): 860-2[PubMed]
  • 9. Rao PS, Asheervadam Y, Khaleelullah M, Rao NS, Murray RD. Hymexelsin, an Apiose-Containing Scopoletin Glycoside from the Stem Bark of Hymenodictyon excelsum. J Nat Prod. 1988; 51(5): 959-61[DOI][PubMed]
  • 10. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants.
  • 11. Kar B, Nepal A, Kumar RBS, Dolai N, Bhattacharya S, Mazumder UK, et al. Antioxidant and anti-inflammatory properties Hymenodictyon excelsum bark. Orient Pharm Exp Med. 2013; 13(2): 103–111
  • 12.
  • 13.
  • 14.
  • 15. Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006; 49(11): 3315-21[DOI][PubMed]
  • 16. Biljali S, Hadjimitova VA, Topashka-Ancheva MN, Momekova DB, Traykov TT, Karaivanova MH. Antioxidant and antiradical properties of esculin, and its effect in a model of epirubicin-induced bone marrow toxicity. Folia Med (Plovdiv). 2012; 54(3): 42-9[PubMed]
  • 17. Nawab A, Yunus M, Mahdi AA, Gupta S. Evaluation of anticancer properties of medicinal plants from the Indian sub-continent. Mol Cellular Pharmacol. 2011; 3(1): 21-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments